
Get latest articles and stories on India at LatestLY. India's central drug regulator has rejected Dr Reddy's Laboratories' application seeking approval for full marketing authorisation of anti-viral drug remdesivir which has so far been allowed restricted emergency use on COVID-19 patients in the country.